Galinsky R E, Nelson E B, Rollins D E
Department of Pharmaceutics, College of Pharmacy, University of Utah, Salt Lake City.
Eur J Clin Pharmacol. 1987;33(4):391-6. doi: 10.1007/BF00637636.
This study examined the effect of metyrapone on the elimination rate of acetaminophen and on the apparent formation rate of acetaminophen metabolites in man. Metyrapone treatment, 1.5 g, increased the half-life of acetaminophen, decreased the fraction of the dose recovered in the urine as the glucuronide and increased the fraction of the dose recovered in urine as the sulfate and mercapturate conjugates. The apparent rate constant for the formation of acetaminophen glucuronide was significantly decreased by metyrapone while the apparent rate constants for the formation of the sulfate and mercapturic acid metabolites were unchanged or slightly increased, respectively. These data indicate that metyrapone inhibits acetaminophen glucuronidation and possibly enhances the oxidation of acetaminophen to its quantitatively minor yet highly toxic reactive metabolite. The extent to which the parallel pathways of acetaminophen elimination are also affected by inhibitors of cytochrome P-450-mediated oxidation will limit the efficacy of these types of potential antidotes for the treatment of acetaminophen overdose.
本研究考察了甲吡酮对乙酰氨基酚消除率以及对人体中乙酰氨基酚代谢物表观生成率的影响。1.5克甲吡酮治疗可增加乙酰氨基酚的半衰期,降低以葡萄糖醛酸苷形式在尿液中回收的剂量分数,并增加以硫酸盐和硫醚氨酸结合物形式在尿液中回收的剂量分数。甲吡酮显著降低了乙酰氨基酚葡萄糖醛酸苷的表观生成速率常数,而硫酸盐和硫醚氨酸代谢物的表观生成速率常数分别未改变或略有增加。这些数据表明,甲吡酮抑制乙酰氨基酚葡萄糖醛酸化,并可能增强乙酰氨基酚氧化为其数量较少但毒性很强的活性代谢物。细胞色素P - 450介导的氧化抑制剂对乙酰氨基酚消除的平行途径的影响程度将限制这类潜在解毒剂治疗乙酰氨基酚过量的疗效。